Home › Breast Cancer › Illinois › Waukegan
Breast Cancer clinical trials in Waukegan, IL
12 studies for Breast Cancer are looking for participants at sites in and around Waukegan (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RecruitingPhase 2
- City of Hope Chicago, Zion · 6 mi away
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RecruitingPhase 1/2
- City of Hope, Chicago, Zion · 6 mi away
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
RecruitingPhase 1/2
- City of Hope® Cancer Center Chicago, Zion · 6 mi away
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecruitingPhase 1
- City of Hope - Chicago, Zion · 6 mi away
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
RecruitingPhase 1/2
- City of Hope® Cancer Center Chicago, Zion · 6 mi away
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RecruitingPhase 3
- City of Hope® Cancer Center Chicago, Zion · 6 mi away
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
- and 1 more
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RecruitingPhase 3
- City of Hope - Cancer Center Chicago, Zion · 6 mi away
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi away
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecruitingPhase 3
- Midwestern Regional Medical Center, Zion · 6 mi away
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- and 2 more
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Waukegan
- Non-Small Cell Lung Cancer16 studies
- Lung Cancer16 studies
- Ulcerative Colitis7 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Ovarian Cancer6 studies
- Metastatic Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Colorectal Cancer6 studies
- Prostate Cancer6 studies
- Melanoma5 studies
- Acute Myeloid Leukemia5 studies
- Crohn's Disease5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.